Medicine
Showing 501-510 of 2,393 Results
-
Nikki Duong, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on quality improvement and patient reported outcomes in people with cirrhosis. I also have interests in expanding our breadth of knowledge in caring for patients with gastrointestinal and liver disorders who identify as a sexual and gender minority.
-
George Duran
Cancer Biologist and Laboratory Manager, Medicine - Med/Oncology
Current Role at StanfordCancer biologist specializing in the development of novel chemotherapeutic agents and in mechanisms of drug resistance. Current research ranges from molecular studies to further understand the heterogeneity of T-cell lymphomas, to translational studies of molecular determinants of therapeutic response, and clinical trials that use the body’s immune system to fight cancer cells.
Original research contributions have resulted in the authorship of over eighty publications. -
Benjamin J. Durant, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Benjamin Durant is a board-certified family medicine doctor at Stanford Health Care and a clinical assistant professor in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine.
Dr. Durant provides complete primary care for people of all ages, with a strong focus on health equity and supporting underserved communities. His clinical interests include outpatient care, prenatal and reproductive health, and treating substance use disorders. He has extensive experience in street medicine and mobile outreach to care for people experiencing homelessness. Dr. Durant takes a trauma-informed, relationship-based approach, building trust and meeting patients where they are.
His academic and service work has focused on improving access to care, training health care workers in under-resourced areas, and helping patients who face challenges like poverty, housing insecurity, or limited access to services. Dr. Durant’s approach to medicine is built on dignity, trust, and long-term relationships. He is committed to understanding and addressing the social factors that affect health. He has also volunteered internationally in Kenya and Haiti. -
Asiri Ediriwickrema MD, PhD
Assistant Professor of Medicine (Hematology)
BioAsiri Ediriwickrema, MD, PhD, is a physician-scientist who leads a systems hematology laboratory at Stanford and directs a clinical practice focused on myelodysplastic neoplasms and clonal hematopoiesis. Our research group studies hematopoiesis—the complex process by which hematopoietic stem cells generate the diverse blood cells essential for health throughout life. Our mission is to understand how individual blood cells change during aging and cancer development, with particular focus on how dysregulation of this process leads to cytopenias and hematologic malignancies.
We integrate expertise spanning clinical medicine, functional hematology, molecular and cellular biology, genomics, bioinformatics, and machine learning. By combining advanced experimental techniques with computational approaches, we examine blood cell development and function at single-cell resolution. Our work aims to identify the earliest cellular changes in cancer development, map how stem cells interact within their tissue environments, and develop AI-powered tools that predict stem cell behavior and disease progression. Our goal is to translate these efforts into improved diagnostics and precision therapeutic strategies for patients with blood disorders and malignancies.
Dr. Ediriwickrema earned his undergraduate degree in Engineering from the Massachusetts Institute of Technology, his MD (Cum Laude) from Yale University, and his PhD from Stanford University. He completed his residency in Internal Medicine and fellowship in Hematology at Stanford, where he also conducted his doctoral and postdoctoral research in the laboratory of Dr. Ravi Majeti. His research identified novel populations of multipotent progenitor cells in normal hematopoiesis and leukemia stem cells in acute myeloid leukemia (AML).
